Bayer's hemophilia A drug gets U.S. FDA approval

Mail Online -

Mail Online—Aug 30 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Bayer AG's drug for the treatment of hemophilia A, a rare genetic disorder in...

Bayer's hemophilia A drug gets FDA approval. The U.S. Food and Drug Administration on Thursday approved Bayer AG's drug for the treatment of hemophilia A, a rare genetic disorder in which the blood does not clot normally, the company said in a statement.